Product Information
ELIQUIS 5 MG TABLET is a brand product labeled by E.R. Squibb & Sons, L.L.C., priced at $5.5211 per EA under NDC 00003089421. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Dec 28, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
E.R. Squibb & Sons, L.L.C.NDC
00003089421
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
APIXABANApproval Type
New Drug (NDA)
FDA Application
NDA202155FDA Approved
12/28/2012
TE Code
AB
On Market Since
12/28/2012
Pharmacological Classes
Price Statistics
The NADAC for ELIQUIS 5 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 28.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.5211 per EA |
|---|---|
| All-time high | $9.7008 (May 14, 2025) |
| All-time low | $4.3092 (Nov 28, 2013) |
| 52-week high | $9.6955 |
| 52-week low | $5.5211 |
| Median price | $7.1119 |
| Average price | $7.1974 |
| Largest weekly change | -43.0% (Jan 14, 2026) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ELIQUIS 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ELIQUIS 5 MG TABLET, manufactured by E.R. Squibb & Sons, L.L.C., is $5.5211 per EA (NDC 00003089421), effective Aug 19, 2026.
How has the price of ELIQUIS 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ELIQUIS 5 MG TABLET has risen 28.1%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ELIQUIS 5 MG TABLET?
Since Nov 28, 2013, the NADAC for ELIQUIS 5 MG TABLET has ranged from a low of $4.3092 (Nov 28, 2013) to a high of $9.7008 (May 14, 2025), with a median of $7.1119 per EA.
Are there cheaper alternatives to ELIQUIS 5 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ELIQUIS 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ELIQUIS 5 MG TABLET?
ELIQUIS 5 MG TABLET (NDC 00003089421) is labeled by E.R. Squibb & Sons, L.L.C., and CMS classifies it as a brand product.